Morgan Stanley’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-51,626
| Closed | -$14K | – | 8090 |
|
|
2022
Q3 | $14K | Buy |
51,626
+12,137
| +31% | +$5.3K | ﹤0.01% | 6965 |
|
|
2022
Q2 | $30K | Sell |
39,489
-3,549
| -8% | -$3.16K | ﹤0.01% | 6844 |
|
|
2022
Q1 | $46K | Sell |
43,038
-209,827
| -83% | -$381K | ﹤0.01% | 6754 |
|
|
2021
Q4 | $480K | Sell |
252,865
-43,047
| -15% | -$103K | ﹤0.01% | 5578 |
|
|
2021
Q3 | $890K | Buy |
295,912
+70,623
| +31% | +$252K | ﹤0.01% | 5128 |
|
|
2021
Q2 | $879K | Buy |
225,289
+123,550
| +121% | +$512K | ﹤0.01% | 5159 |
|
|
2021
Q1 | $516K | Buy |
101,739
+50,575
| +99% | +$262K | ﹤0.01% | 5133 |
|
|
2020
Q4 | $209K | Buy |
51,164
+40,243
| +368% | +$198K | ﹤0.01% | 5569 |
|
|
2020
Q3 | $53K | Sell |
10,921
-11,253
| -51% | -$61.5K | ﹤0.01% | 5706 |
|
|
2020
Q2 | $123K | Buy |
22,174
+12,850
| +138% | +$58.9K | ﹤0.01% | 5303 |
|
|
2020
Q1 | $31K | Sell |
9,324
-11,524
| -55% | -$60.7K | ﹤0.01% | 5652 |
|
|
2019
Q4 | $94K | Sell |
20,848
-9,164
| -31% | -$29K | ﹤0.01% | 5672 |
|
|
2019
Q3 | $125K | Buy |
30,012
+27,412
| +1,054% | +$99K | ﹤0.01% | 5361 |
|
|
2019
Q2 | $10K | Sell |
2,600
-21,385
| -89% | -$87.6K | ﹤0.01% | 6144 |
|
|
2019
Q1 | $101K | Sell |
23,985
-12,302
| -34% | -$43K | ﹤0.01% | 5388 |
|
|
2018
Q4 | $90K | Sell |
36,287
-1,908
| -5% | -$11.2K | ﹤0.01% | 5590 |
|
|
2018
Q3 | $279K | Sell |
38,195
-6,455
| -14% | -$28.3K | ﹤0.01% | 5303 |
|
|
2018
Q2 | $165K | Sell |
44,650
-1,727
| -4% | -$7.99K | ﹤0.01% | 5603 |
|
|
2018
Q1 | $178K | Sell |
46,377
-11,745
| -20% | -$49.4K | ﹤0.01% | 5517 |
|
|
2017
Q4 | $209K | Sell |
58,122
-4,104
| -7% | -$15.5K | ﹤0.01% | 5391 |
|
|
2017
Q3 | $246K | Sell |
62,226
-72,900
| -54% | -$335K | ﹤0.01% | 5251 |
|
|
2017
Q2 | $689K | Sell |
135,126
-33,130
| -20% | -$186K | ﹤0.01% | 4616 |
|
|
2017
Q1 | $1.16M | Buy |
168,256
+36,117
| +27% | +$282K | ﹤0.01% | 4265 |
|
|
2016
Q4 | $1.24M | Buy |
132,139
+78,270
| +145% | +$705K | ﹤0.01% | 4305 |
|
|
2016
Q3 | $526K | Sell |
53,869
-12,185
| -18% | -$164K | ﹤0.01% | 4495 |
|
|
2016
Q2 | $933K | Buy |
66,054
+25,557
| +63% | +$399K | ﹤0.01% | 4026 |
|
|
2016
Q1 | $567K | Buy |
40,497
+22,267
| +122% | +$327K | ﹤0.01% | 4348 |
|
|
2015
Q4 | $372K | Buy |
18,230
+11,887
| +187% | +$183K | ﹤0.01% | 4738 |
|
|
2015
Q3 | $84K | Sell |
6,343
-766
| -11% | -$12.7K | ﹤0.01% | 5497 |
|
|
2015
Q2 | $109K | Sell |
7,109
-2,192
| -24% | -$42K | ﹤0.01% | 5542 |
|
|
2015
Q1 | $186K | Buy |
9,301
+2,990
| +47% | +$66.9K | ﹤0.01% | 5251 |
|
|
2014
Q4 | $132K | Buy |
6,311
+4,034
| +177% | +$82.1K | ﹤0.01% | 5428 |
|
|
2014
Q3 | $42K | Buy |
2,277
+1,941
| +578% | +$35.2K | ﹤0.01% | 5790 |
|
|
2014
Q2 | $8K | Buy |
+336
| New | +$5.92K | ﹤0.01% | 6234 |
|
Morgan Stanley's AGTC Position: Q4 2022 in Review
Morgan Stanley sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 51,626 shares — an estimated $14K sold.
Morgan Stanley first reported a position in AGTC in Q2 2014 and held it in 34 quarters. The position peaked at $1.24M in Q4 2016. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Morgan Stanley reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Morgan Stanley sold 51,626 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $14K.
- Morgan Stanley first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 34 quarters.
- Morgan Stanley's Applied Genetic Technologies Corporation position peaked at $1.24M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.